Perinatal HIV-1 transmission among low income women participants in the HIV/AIDS Control Program in Southern Brazil: a cohort study

被引:21
作者
Kreitchmann, R
Fuchs, SC
Suffert, T
Preussler, G
机构
[1] Secretaria Municipal Saude, Ctr Municipal Atendimento Doencas Sexualmente, BR-90850530 Rio Grande Do Sul, Brazil
[2] Univ Fed Rio Grande Sul, Sch Med, Programa Posgrad Med Ciencias Med, BR-90046900 Porto Alegre, RS, Brazil
[3] Univ Fed Rio Grande Sul, Sch Med, Dept Social Med, BR-90046900 Porto Alegre, RS, Brazil
关键词
D O I
10.1111/j.1471-0528.2004.00147.x
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective To determine the rate and factors associated with perinatal transmission among women infected with HIV-1. Design Cohort study. Setting Centro Municipal de Atendimento ern DST/AIDS is a major reference centre for HIV treatment in Porto Alegre city, southern Brazil. Population Pregnant and puerperal women infected with HIV-1. Methods Women were enrolled during pregnancy and seen monthly at the antenatal care centre. Those detected at delivery that presented at the centre within the first 10 days of postpartum were included. Maternal, obstetric and infant-related characteristics were ascertained and testing for CD4 cell count, HIV PCR/RNA assay, anti-HCV, HBSAg and syphilis were performed. Antiretrovirals and formula were provided free of charge following Brazilian guidelines. Main outcome measure HIV-1 infection status in the infant. Results Perinatal transmission was assessed in 343 children (95% of the whole sample). Overall, the transmission rate was 3.2% (95% CI: 1.7-5.8%.). Perinatal transmission rates increased with maternal viral load (greater than or equal to10,000 copies/mL; RR: 11.27; 95% CI: 1.38-92.23). In multivariate analyses, the only independent risk factor for perinatal transmission was the maternal viral load at baseline (OR = 2.72 per log increase in the number of copies; 95% CI: 1.17-6.50). Conclusion Perinatal transmission rate was low among HIV-1 infected women in clinical care and on antiretroviral therapy despite poor socio-economic conditions. Viral load level was the only independent predictor of perinatal transmission. It is possible to prevent HIV-1 perinatal transmission in a developing country if we provide antiretrovirals and formula.
引用
收藏
页码:579 / 584
页数:6
相关论文
共 21 条
[1]   The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1 -: A meta-analysis of 15 prospective cohort studies [J].
Andiman, W ;
Boucher, M ;
Burns, D ;
Bryson, Y ;
Farley, J ;
Fowler, H ;
Gabiano, C ;
Galli, L ;
Hutto, C ;
Kind, C ;
Korber, B ;
Kovacs, A ;
Krogstad, P ;
Landesman, S ;
Lapointe, N ;
Lemay, M ;
Lew, J ;
Mandelbrot, L ;
Mayaux, MJ ;
Mellins, R ;
Minkoff, H ;
Mofenson, L ;
Nielsen, K ;
Newell, ML ;
Pardi, G ;
Peavy, H ;
Peckham, C ;
Read, J ;
Rother, C ;
Rudin, C ;
Scott, G ;
Semprini, A ;
Shearer, W ;
Simonds, R ;
Simpson, B ;
Stek, A ;
Tovo, PA ;
Tuomala, R ;
Van Dyke, R ;
Weedon, J ;
de Martino, M ;
Lindsay, M ;
Belair, S ;
Chan, L ;
Harris, D ;
Kalish, L ;
Muenz, L ;
Nugent, R ;
Schluchter, M ;
Durako, S .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (13) :977-987
[2]   A case-control study of HIV seroconversion in health care workers after percutaneous exposure [J].
Cardo, DM ;
Culver, DH ;
Ciesielski, CA ;
Srivastava, PU ;
Marcus, R ;
Abiteboul, D ;
Heptonstall, J ;
Ippolito, G ;
Lot, F ;
McKibben, P ;
Bell, DM .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (21) :1485-1490
[3]   REDUCTION OF MATERNAL-INFANT TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WITH ZIDOVUDINE TREATMENT [J].
CONNOR, EM ;
SPERLING, RS ;
GELBER, R ;
KISELEV, P ;
SCOTT, G ;
OSULLIVAN, MJ ;
VANDYKE, R ;
BEY, M ;
SHEARER, W ;
JACOBSON, RL ;
JIMENEZ, E ;
ONEILL, E ;
BAZIN, B ;
DELFRAISSY, JF ;
CULNANE, M ;
COOMBS, R ;
ELKINS, M ;
MOYE, J ;
STRATTON, P ;
BALSLEY, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (18) :1173-1180
[4]  
Cooper ER, 2002, J ACQ IMMUN DEF SYND, V29, P484, DOI 10.1097/00126334-200204150-00009
[5]   Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission - A randomized trial [J].
Dorenbaum, A ;
Cunningham, CK ;
Gelber, RD ;
Culnane, M ;
Mofenson, L ;
Britto, P ;
Rekacewicz, C ;
Newell, ML ;
Delfraissy, JF ;
Cunningham-Schrader, B ;
Mirochnick, M ;
Sullivan, JL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (02) :189-198
[6]   Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission [J].
Garcia, PM ;
Kalish, LA ;
Pitt, J ;
Minkoff, H ;
Quinn, TC ;
Burchett, SK ;
Kornegay, J ;
Jackson, B ;
Moye, J ;
Hanson, C ;
Zorrilla, C ;
Lew, JF .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (06) :394-402
[7]  
HAMMERS FF, 2003, J ACQUIR IMMUNE D S1, V32, P39
[8]   Trends in perinatal transmission of HIV/AIDS in the United States [J].
Lindegren, ML ;
Byers, RH ;
Thomas, P ;
Davis, SF ;
Caldwell, B ;
Rogers, M ;
Gwinn, M ;
Ward, JW ;
Fleming, PL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (06) :531-538
[9]   Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1 [J].
Mandelbrot, L ;
Landreau-Mascaro, A ;
Rekacewicz, C ;
Berrebi, A ;
Bénifla, JL ;
Burgard, M ;
Lachassine, E ;
Barret, B ;
Chaix, ML ;
Bongain, A ;
Ciraru-Vigneron, N ;
Crenn-Hébert, C ;
Delfraissy, JF ;
Rouzioux, C ;
Mayaux, MJ ;
Blanche, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (16) :2083-2093
[10]   Maternal virus load during pregnancy and mother-to-child transmission of human immunodeficiency virus type 1: The French Perinatal Cohort studies [J].
Mayaux, MJ ;
Dussaix, E ;
Isopet, J ;
Rekacewicz, C ;
Mandelbrot, L ;
CiraruVigneron, N ;
Allemon, MC ;
Chambrin, V ;
Katlama, C ;
Delfraissy, JF ;
Puel, J .
JOURNAL OF INFECTIOUS DISEASES, 1997, 175 (01) :172-175